CorMedix to acquire Heron Therapeutics assets, reports Q3 2026 resultsNov 12Quarterly updateCorMedix Inc.
CorMedix to acquire nearly all of Heron Therapeutics' assets in cash-and-stock dealNov 9M&ACorMedix Inc.Heron Therapeutics, Inc. /De/Updated
FDA accepts CorMedix sNDA for Rezzayo, grants priority reviewOct 19Regulatory milestoneCorMedix Inc.Mundipharma
CorMedix reports Q2 2026 results, flags REZZAYO filing and DefenCath supply dealAug 13Quarterly updateCorMedix Inc.rezafungin